Recently, Orion Market Research (OMR) added an industrial report on Global Congenital Heart Disease Market in its portfolio. The market for congenital heart disease across the globe is expected to grow consistently positive during the forecast period. The factors driving the growth of the Global Congenital Heart Disease Market are raising prevalence of congenital heart disease and rise in adoption of minimally invasive procedures. Further, large number of dominating market players, growing demand for catheterization and application of cardiac biomarkers in congenital heart disease treatment are also considered as a major factor for driving the growth of the global congenital heart disease market during forecast period. In addition, advances and research in congenital heart disease and significant research funding for various projects are creating enormous opportunities for the global congenital heart disease market in coming years.

A full report of the Global Congenital Heart Disease Market is available at: https://www.omrglobal.com/industry-reports/congenital-heart-disease-market/

Furthermore, the global congenital heart disease market is segmented on the basis of defect type, diagnosis, treatment and end-users. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

Market Segmentation
1. Global Congenital Heart Disease Market by Defect Type
• Heart Valve Defects
• Heart Wall Defects
• Blood Vessel Defects
2. Global Congenital Heart Disease Market by Diagnosis
• Echocardiogram
• Chest X-Ray
• MRI Scan
• Other
3. Global Congenital Heart Disease Market by Treatment
• Medications
• Implantable Heart Devices
• Catheter Procedures
• Open-Heart Surgery
• Heart Transplant
4. Global Congenital Heart Disease Market by End User
• Hospitals and Clinics
• Diagnostic Centers
• Other

Region Covered
• North America (the US and Canada)
• Europe (UK, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, South Korea, and Japan)
• Rest of the World (the Middle East & Africa and Latin America)


Company Profile
• Abbott Diagnostics
• Array Biopharma, Inc.
• AstraZeneca PLC
• Becton and Dickson & Co.
• BG Medicine, Inc.
• Bio-Rad Laboratories, Inc.
• Boston Scientific Corp.
• Covance
• Critical Diagnostics
• F. Hoffmann-La Roche, Ltd.
• GlaxoSmithKline PLC
• Janssen Pharmaceuticals, Inc.
• Medtronic
• Merck & Co., Inc.
• Mylan N.V.
• Novartis International AG
• Pfizer, Inc.
• Randox Laboratories, Ltd.
• Response Biomedical Corp.
• Sanofi S.A.
• Siemens Healthcare
• Thermo Fisher Scientific, Inc.
• Vericel Corp.

For Free Sample Reports: https://www.omrglobal.com/request-sample/congenital-heart-disease-market

The key objectives of the Congenital Heart Disease Market study:
• To analyze the Congenital Heart Disease Market by segments with historical data of 2017 and 2018 and forecast to 2025.
• To study the key factors influencing the growth of the market.
• Focuses on the key leaders to define and analyze the sales volume, value, share, competitive landscapes, SWOT analysis, and development plans.
• To analyze the Congenital Heart Disease Market growth, global trends, future prospectus and contribution to the market.

For Related Reports visit:
• Glass Curtain Wall Market
• Dredging Market

About Orion Market Research
Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, company profiling, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667,+91 780-304-0404